Abstract
In the field of dermatology, psoriasis patients are more prone to therapy non-adherence. Patients’ perception of psoriasis, choice of medication and personal factors are some of the causes for therapy non-adherence. A positive physician-patient relationship is of paramount importance to achieve improved therapy adherence results and both have a responsibility. Doctors must be aware of pros and cons concerning medicine and patients economy. Early follow-up consultations are important to encourage patients’ treatment behaviour and to substitute medicine if necessary. Emails, daily text messages and app downloads are tools which can help the patients to remember their medicine (e.g. dosage, time intervals) and doctors consultations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Zachariae R, Claus O, Zachariae C, Lei U, Pedersen AF (2008) Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 88:121–127
Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, Schäfer G, EUROPSO Patient Survey Group (2006) European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 155:729–736
Bewley A, Burrage DM, Ersser SJ, Hansen M, Ward C (2014) Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol 28:763–770
Burroni AG, Fassino M, Torti A, Visentin E (2015) How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey. Patient Relat Outcome Meas 16:9–17
Feldman SR (2013) Disease burden and treatment adherence in psoriasis patients. Cutis 92:258–263
Eastman WJ, Malahias S, Delconte J, DiBenedetti D (2014) Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis 94:46–53
Puig L, Carrascosa JM, Belinchón I, Fernández-Redondo V, Carretero G, Ruiz-Carrascosa JC, Careaga JM, de la Cueva P, Gárate MT, Ribera M, Panel de Expertos del Consenso Delphi sobre Tratamiento tópico de la psoriasis, Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (2013) Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the psoriasis group of the Spanish Academy of dermatology and venereology. Actas Dermosifiliogr 104:488–496
Storm A, Andersen SE, Benfeldt E, Serup J (2008) One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 59:27–33
Storm A, Benfeldt E, Andersen SE, Serup J (2008) A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 59:975–980
Brown KK, Rehmus WE, Kimball AB (2006) Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 55:607–613
Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, Aractingi S, Aubin F, Bachelez H, Cribier B, Jullien D, Le Maître M, Richard MA, Ortonne JP, Paul C (2012) Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 26:61–67
Ulff E, Maroti M, Kettis-Lindblad A, Kjellgren KI, Ahlner J, Ring L, Serup J (2007) Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites. Br J Dermatol 156:974–978
Schaefer H, Redelmeier TE (1996) Skin barrier: principles of percutaneous absorption. Basel, Karger
Bronaugh RL, Maibach HI (2005) Percutaneous absorption, drugs-cosmetics-mechanisms-methodology, vol 55, 4th edn. Taylor and Francis Group, Boca Raton
Ulff E, Maroti M, Serup J (2013) Fluorescent cream used as an educational intervention to improve the effectiveness of self-application by patients with atopic dermatitis. J Dermatolog Treat 24:268–271
Gartner L, Tarras-Wahlberg C (1984) A double-blind controlled evaluation of diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema. J Int Med Res 12:59–61
Fouéré S, Adjadj L, Pawin H (2005) How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol 19:2–6
Halioua B, Maury Le Breton A, de Fontaubert A, Roussel ME, Stalder JF (2015) Treatment refusal among patients with psoriasis. J Dermatolog Treat 26:396–400
Finch T, Shim TN, Roberts L, Johnson O (2015) Treatment satisfaction among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol 8:26–30
Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Goerdt S, Peitsch WK (2015) Treatment satisfaction of patients with psoriasis. Acta Derm Venereol 95:572–578
Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A, Katoh N, Murota H, Takeuchi S, Sugaya M, Tanioka M, Kaneko S, Masuda K, Hiragun T, Inomata N, Kitami Y, Tsunemi Y, Abe S, Kobayashi M, Morisky DE, Furue M (2015) Poor adherence to medication as assessed by the Morisky medication adherence scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol 42:367–372
Roenigk HH (1994) Methotrexate. In: Dubertret L. Psoriasis (ed.). ISED Italy. pp 162–173
Inzinger M, Weger W, Heschl B, Salmhofer W, Quehenberger F, Wolf P (2013) Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions. J Eur Acad Dermatol Venereol 27:861–866
Zachariae C, Mørk NJ, Reunala T, Lorentzen H, Falk E, Karvonen SL, Johannesson A, Claréus B, Skov L, Mørk G, Walker S, Qvitzau S (2008) The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy. Acta Derm Venereol 88:495–501
Migliore A, Cusano F, Bianchi G, Malara G, Epis O, De Pità O (2015) Management of psoriatic arthritis: should the interaction between dermatologists and rheumatologists in clinical practice be intensified? J Biol Regul Homeost Agents 29:547–561
Nikiphorou E, Negoescu A, Fitzpatrick JD, Goudie CT, Badcock A, Östör AJ, Malaviya AP (2014) Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. Clin Rheumatol 33:609–614
McHugh NJ (2015) Early psoriatic arthritis. Rheum Dis Clin North Am 41:615–622
You HS, Kim GW, Cho HH, Kim WJ, Mun JH, Song M, Kim HS, Ko HC, Kim MB, Lee SG, Lee IS, Kim BS (2015) Screening for psoriatic arthritis in Korean psoriasis patients using the psoriatic arthritis screening evaluation questionnaire. Ann Dermatol 27:265–268
Roll A, Reich K, Boer A (2007) Use of fumaric acid esters in psoriasis. Indian J Dermatol Venereol Leprol 73:133–137
Ismail N, Collins P, Rogers S, Kirby B, Lally A (2014) Drug survival of fumaric acid esters for psoriasis: a retrospective study. Br J Dermatol 171:397–402
Swimberghe S, Ghislain PD, Daci E, Allewaert K, Denhaerynck K, Hermans C, Pacheco C, Vancayzeele S, MacDonald K, Abraham I (2013) Clinical, quality of life, patient adherence, and safety outcomes of short-course (12 weeks) treatment with cyclosporine in patients with severe psoriasis (the practice study). Ann Dermatol 25:28–35
Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H, Barker J, Dauden E, de Jong EM, Feist E, Jacobs A, Jobling R, Kemény L, Maccarone M, Mrowietz U, Papp KA, Paul C, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Yawalkar N (2015) European S3-guidelines on the systemic treatment of psoriasis vulgaris – update 2015 – short version – EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 29:2277–2294
Poulin Y, Papp KA, Wasel NR et al (2010) A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol 49:1368–1375
DiBonaventura M, Wagner S, Waters H, Carter C (2010) Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis. J Drugs Dermatol 9:938–944
Jones-Caballero M, Unaeze J, Penas PF, Stern RS (2007) Use of biological agents in patients with moderate to severe psoriasis: a cohort based perspective. Arch Dermatol 143:846–850
Mahler R, Jackson C, Ijacu H (2009) The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey. J Cutan Med Surg 13:283–293
Bhosle MJ, Feldman SR, Camacho FT, Whitmire TJ, Nahata MC, Balkrishnan R (2006) Medication adherence and health care costs associated with biologics in Medicaid- enrolled patients with psoriasis. J Dermatolog Treat 17:294–301
Gisondi P, Tessari G, Di Mercurio M et al (2013) Retention rate of systemic drugs in patients with chronic plaque psoriasis. Clin Dermatol 1:8–14
Ross C, Marshman G, Grillo M, Stanford T (2015) Biological therapies for psoriasis: adherence and outcome analysis from a clinical perspective. Australas J Dermatol (Epub ahead of print)
Drugs.com (visited 3 Dec 2015), searched titles: Ustekinumab, infliximab, adalimumab and etanercept
Zhang M, Brenneman SK, Carter CT, Essoi BL, Farahi K, Johnson MP, Lee S, Olson WH (2015) Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis. Patient Prefer Adherence 16(8):777–784
Kalia S, Toosi B, Bansback N et al (2014) Assessing adherence with phototherapy protocols. J Am Acad Dermatol 71:1259–1261
Yentzer BA, Yelverton CB, Pearce DJ et al (2008) Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. J Am Acad Dermatol 59:577–581
Lings C, Kragballe K (2008) Klimabehandling til psoriasis (Eng: climatherapy for psoriasis), Århus Hospital, Denmark
Carroll CL, Feldman SR, Camacho FT, Balkrishnan R (2004) Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 151:895–897
Davis SA, Feldman SR (2013) Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol 149:490–491
Gelfand JM, Wang S, Takeshita J, Robertson AD et al (2013) Response to “Using Effects to Improve Adherence in Clinical Practice: Lessons from Clinical Trials”. JAMA Dermatol 149:490–491
Cramer JA, Scheyer RD, Mattson RH (1990) Compliance declines between clinic visits. Arch Intern Med 150:1509–1510
Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R (2007) Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57:81–83
Davis SA, Lin HC, Yu CH, Balkrishnan R, Feldman SR (2014) Underuse of early follow-up visits: a missed opportunity to improve patients’ adherence. J Drugs Dermatol 13:833–836
Balato N, Megna M, Di Costanzo L, Balato A, Ayala F (2013) Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol 168:201–205
Storm A, Benfeldt E, Andersen SE, Serup J (2009) Basic drug information given by physicians is deficient, and patients’ knowledge low. J Dermatolog Treat 20:190–193
Zschocke I, Mrowietz U, Karakasili E, Reich K (2014) Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol 28:4–9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hutton Carlsen, K., Olasz, A., Carlsen, K.M., Serup, J. (2016). Psoriasis and Adherence to Therapy: Individual, Treatment-Related and General Factors. In: Davis, S. (eds) Adherence in Dermatology. Adis, Cham. https://doi.org/10.1007/978-3-319-30994-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-30994-1_10
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-30992-7
Online ISBN: 978-3-319-30994-1
eBook Packages: MedicineMedicine (R0)